Acumapimod – m-entrepreneurship.com

Product Name :
Acumapimod

Search keywords :
Acumapimod

drugId :
null

Target Vo:
P38 mitogen-activated protein kinase

Target Vo Short Name :
p38 MAPK

Moa_Name:
P38 mitogen-activated protein kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Acute Kidney Injury

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SQSTM1/p62 Antibody (YA062)
beta Tubulin Antibody (YA839)
p16 Antibody: p16 Antibody is an unconjugated, approximately 16 kDa, rabbit-derived, anti-p16 monoclonal antibody. p16 Antibody can be used for: WB, IHC-P expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts